Breaking News Instant updates and real-time market news.

TME

Tencent Music

$14.43

0.44 (3.15%)

, DXC

DXC Technology

$29.61

-0.47 (-1.56%)

13:05
11/11/19
11/11
13:05
11/11/19
13:05

Notable companies reporting after market close

Notable companies reporting after the market close, with earnings consensus, include Tencent Music Entertainment (TME), consensus 9c... DXC Technology (DXC), consensus $1.42... TerraForm Power (TERP), consensus 5c... Franco-Nevada (FNV), consensus 27c... UGI Corporation (UGI), consensus (4c).

TME

Tencent Music

$14.43

0.44 (3.15%)

DXC

DXC Technology

$29.61

-0.47 (-1.56%)

TERP

TerraForm Power

$16.57

0.07 (0.42%)

FNV

Franco-Nevada

$95.95

0.34 (0.36%)

UGI

UGI Corporation

$46.23

-0.33 (-0.71%)

  • 11

    Nov

  • 11

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

TME Tencent Music
$14.43

0.44 (3.15%)

10/18/19
NWST
10/18/19
INITIATION
Target $16
NWST
Buy
Tencent Music initiated with a Buy at New Street
New Street initiated coverage of Tencent Music with a Buy rating and $16 price target.
10/08/19
CHRS
10/08/19
UPGRADE
Target $16
CHRS
Buy
Tencent Music upgraded to Buy from Hold at China Renaissance
China Renaissance analyst Alex Liu upgraded Tencent Music to Buy from Hold with an unchanged price target of $16, stating that he expects paying subscriber upside to drive the stock higher over the next 12-18 months. Liu projects paying users to grow 3M quarter-over-quarter to reach 34M in Q3, which he expects to be a positive catalyst for the stock, he tells investors.
11/03/19
THCP
11/03/19
NO CHANGE
THCP
TH Data Capital expects Tencent Music Q3 revenue to beat consensus
TH Data Capital analyst Tian Hou, who does not rate Tencent Music, said she is "positive" on Tencent's Q3 earnings, and expects the company to beat on revenue when it reports after the market close on November 11. The analyst added that this is the first time since the company's IPO that she believes it is likely to outperform instead of missing expectations. Hou said the drivers are likely to be "1) more paid songs under the Online Music Services line as more popular songs are VIP songs; and 2) the exclusive release of Jay Chou's song was a positive to its paying member growth as well as paying ratio."
09/06/19
SBSH
09/06/19
NO CHANGE
Target $326
SBSH
Buy
NetEase price target raised to $326 from $301 at Citi
Citi analyst Hillman Chan raised his price target for NetEase (NTES) to $326 from $301 saying he's positive on the sale of Kaola to Alibaba (BABA). The disposal signals NetEase's continuous focus on profitability and the additional funding to Cloud Music could make it more competitive versus Tencent Music (TME), Chan tells investors in a research note. The analyst expects investors to gradually assign value to NetEase's remaining non-gaming assets, like Cloud Music, and he keeps a Buy rating on the shares.
DXC DXC Technology
$29.61

-0.47 (-1.56%)

09/26/19
WELS
09/26/19
NO CHANGE
Target $32
WELS
Market Perform
DXC Technology price target lowered to $32 from $46 at Wells Fargo
Wells Fargo analyst Ed Caso raised his price target for DXC Technology to $32 from $46 given the recent unexpected and abrupt resignation of CEO Mike Lawrie and the immediate shift to new CEO Mike Salvino. The analyst notes that investors are increasingly concerned whether DXC can actually revive organic growth without meaningfully reducing the EBITDA margin outlook, while Caso remains concerned about further reductions in the financial outlook. He expects the shares to remain volatile around current levels, and reiterates a Market Perform rating on the stock.
10/08/19
MOFT
10/08/19
NO CHANGE
Target $36
MOFT
Neutral
DXC Technology price target lowered to $36 from $43 at MoffettNathanson
MoffettNathanson analyst Lisa Ellis noted that DXC Technology shares are down 70% over the past twelve months and the company now has a new CEO, making it a good time in her opinion to "hit the 'reset' button" and focus on what is next to come for the company rather than what has already happened. Given her view of the company's revenue, margin and free cash flow outlook Ellis maintains a Neutral rating on the stock and lowered her price target on DXC shares to $36 from $43.
09/12/19
EVER
09/12/19
DOWNGRADE
Target $34
EVER
In Line
Evercore ISI downgrades DXC Technology to In Line following CEO exit
As previously reported, Evercore ISI analyst Rayna Kumar downgraded DXC Technology to In Line from Outperform following the announcement of Mike Lawrie's retirement as President and CEO. Lawrie's track record of strong operational execution had been a key reason for recommending DXC stock and while Kumar likes successor Mike Salvino, the analyst believes the timing of the announcement may suggest that things could get worse before getting better. Kumar reduced the price target on DXC shares to $34 from $63.
09/12/19
09/12/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Square (SQ) assumed with a Hold from Buy at Canaccord with analyst Joseph Vafi saying the stock will continue to react to changes in payment volume growth, which has been showing steady deceleration. 2. Deere (DE) and Caterpillar (CAT) were downgraded to Market Perform from Outperform at Wells Fargo. 3. Prudential (PRU) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Alex Scott saying Voya Financial (VOYA) has a better ability to beat earnings estimates in the near term as well as in 2020 and 2021 relative to Prudential. 4. Invesco (IVZ) downgraded to Neutral from Overweight at JPMorgan with analyst Kenneth Worthington saying continued Oppenheimer outflows "show few signs of slowing," making it unlikely for the stock to outperform despite a cheap valuation. 5. DXC Technology (DXC) was downgraded to In Line from Outperform at Evercore ISI and to Neutral from Positive at Susquehanna. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
TERP TerraForm Power
$16.57

0.07 (0.42%)

10/08/19
LEHM
10/08/19
UPGRADE
Target $61
LEHM
Overweight
Barclays upgrades NextEra to Overweight, downgrades TerraForm to Equal Weight
Barclays analyst Moses Sutton upgraded NextEra Energy Partners (NEP) to Overweight from Equal Weight with a price target of $61, up from $52. NextEra Energy's underperformance relative to TerraForm Power (TERP) "has become a compelling opportunity," Sutton tells investors in a research note. At this point, from numerous perspectives, including price performance, relative yield, and 2020-2021 growth visibility, NextEra Energy screens as the best way to gain an outsized total return in the YieldCos group, contends the analyst. As a result, the analyst upgraded NextEra Energy Partners to Overweight and downgraded TerraForm Power to Equal Weight.
10/08/19
10/08/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Oracle (ORCL), Carbonite (CARB), and Check Point (CHKP) downgraded to Hold from Buy at Jefferies. 2. TerraForm Power (TERP) downgraded to Equal Weight from Overweight at Barclays. 3. Puma Biotechnology (PBYI) downgraded to Sell from Neutral at Goldman Sachs while Nektar Therapeutics (NKTR) was double downgraded to Sell from Buy. 4. Qiagen (QGEN) downgraded to Underweight from Neutral at JPMorgan and to Equal Weight from Overweight at Barclays. 5. Helmerich & Payne (HP) and Patterson-UTI (PTEN) downgraded to Neutral from Buy at BofA/Merrill. Nine Energy Services (NINE) and FTS International (FTSI) downgraded to Underperform from Neutral at BofA/Merrill. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/18/19
09/18/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. FedEx (FDX) downgraded to Hold from Buy at Deutsche Bank and Stifel, to Sector Weight from Overweight at KeyBanc, and to Market Perform from Outperform at BMO Capital. 2. Travelers (TRV) downgraded to Neutral from Buy at BofA/Merrill with analyst Jay Cohen citing valuation. 3. TerraForm Power (TERP) downgraded to Neutral from Overweight at JPMorgan with analyst Mark Strouse citing valuation. 4. Blackstone (BX) downgraded to Neutral from Buy at Citi with analyst William Katz citing valuation. 5. Masco (MAS) downgraded to Neutral from Buy at Buckingham with analyst Megan McGrath saying that given Masco's muted three-year pro forma outlook provided at its investor day on Tuesday, she believes that much further upside to the shares would require a belief that 2021 guidance is meaningfully conservative. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/08/19
LEHM
10/08/19
DOWNGRADE
Target $18
LEHM
Equal Weight
TerraForm Power downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Moses Sutton downgraded TerraForm Power to Equal Weight from Overweight with a $18 price target.
FNV Franco-Nevada
$95.95

0.34 (0.36%)

04/09/19
LEHM
04/09/19
NO CHANGE
LEHM
Barclays still positive on Metals and Mining, downgrades three on valuation
Barclays analyst Matthew Murphy remains positive on shares in the North America Metals and Mining space. The potential for higher recession probabilities could still drive demand for "safe assets," Murphy tells investors in a research note. Further, copper should benefit from a sequential acceleration in China during Q2, says the analyst. He sees several names with "significant upside" and "catalyst potential" including Teck Resources (TECK), Barrick Gold (GOLD), and Newmont Mining (NEM) and Goldcorp (GG). To reflect valuation, Murphy upgraded OceanaGold (OCANF) to Overweight from Equal Weight and downgraded to Equal Weight from Overweight shares of Agnico Eagle (AEM), Franco-Nevada (FNV) and Wheaton Precious Metals (WPM).
05/22/19
RBCM
05/22/19
DOWNGRADE
RBCM
Sector Perform
Franco-Nevada downgraded to Sector Perform from Outperform at RBC Capital
08/08/19
FBCO
08/08/19
NO CHANGE
Target $95
FBCO
Neutral
Franco-Nevada price target raised to $95 from $84 at Credit Suisse
Credit Suisse analyst Fahad Tariq raised his price target for Franco-Nevada to $95 from $84 following a Q2 EPS beat and improved energy guidance. The analyst reiterates a Neutral rating on the shares.
07/23/19
MITR
07/23/19
DOWNGRADE
MITR
Hold
Franco-Nevada downgraded to Hold from Buy at GMP Securities
UGI UGI Corporation
$46.23

-0.33 (-0.71%)

04/03/19
BOFA
04/03/19
UPGRADE
BOFA
Buy
UGI Corporation upgraded to Buy from Neutral at BofA/Merrill
04/03/19
04/03/19
UPGRADE
Target $58

Buy
UGI Corporation upgraded to Buy on valuation at BofA/Merrill
As previously reported, BofA/Merrill upgraded UGI Corporation to Buy from Neutral with a $58 price target. Analyst Dennis Coleman views the sell-off in shares following the acquisition of AmeriGas (APU) as overdone and would be a buyer of shares.
04/05/19
JEFF
04/05/19
UPGRADE
JEFF
Buy
UGI Corporation upgraded to Buy from Hold at Jefferies
Jefferies analyst Christopher Sighinolfi upgraded UGI Corporation to Buy from Hold.
04/05/19
JEFF
04/05/19
NO CHANGE
JEFF
Buy
Jefferies upgrades UGI, downgrades AmeriGas after deal announcement
As previously reported, Jefferies analyst Christopher Sighinolfi upgraded UGI Corporation (UGI) to Buy from Hold and downgraded AmeriGas Partners (APU) to Hold from Buy after the company's recent announcement that UGI will acquire AmeriGas's publicly-held LP units for cash and stock. He views the deal as a "logical solution" with benefits for both and thinks the merger frees up more than $200M per year in cash for UGI while also resulting in EPS accretion and enhanced optionality without any step-out in risk. Since the merger terms implies a $37.50/unit valuation for AmeriGas, the total return potential falls short of the firm's Buy threshold, Sighinolfi said.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
12/06/19
12/06
13:17
12/06/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
12/06/19
12/06
13:16
12/06/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,749.41

8.82 (0.51%)

13:08
12/06/19
12/06
13:08
12/06/19
13:08
Periodicals
Amazon says U.K. soccer streams brought record Prime sign-ups, Guardian says »

Amazon has said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKR

Baker Hughes

$22.28

0.14 (0.63%)

13:05
12/06/19
12/06
13:05
12/06/19
13:05
Hot Stocks
Baker Hughes reports U.S. rig count down 3 to 799 rigs »

Baker Hughes reports the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LDOS

Leidos

$89.77

-0.14 (-0.16%)

, PSN

Parsons

$40.51

0.66 (1.66%)

13:00
12/06/19
12/06
13:00
12/06/19
13:00
Recommendations
Leidos, Parsons analyst commentary  »

Wells says investors…

LDOS

Leidos

$89.77

-0.14 (-0.16%)

PSN

Parsons

$40.51

0.66 (1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

SPY

SPDR S&P 500 ETF Trust

$315.21

3.17 (1.02%)

, VOO

Vanguard S&P 500 ETF

$289.57

2.94 (1.03%)

12:58
12/06/19
12/06
12:58
12/06/19
12:58
Technical Analysis
On The Fly: ETF fund flow highlights »

For the week flows to the…

SPY

SPDR S&P 500 ETF Trust

$315.21

3.17 (1.02%)

VOO

Vanguard S&P 500 ETF

$289.57

2.94 (1.03%)

XLY

Consumer Discretionary Sector SPDR

$121.97

1.19 (0.99%)

XLI

Industrial Select Sector SPDR

$81.21

1.08 (1.35%)

IEF

iShares 7-10 Year Treasury Bond ETF

$110.99

-0.34 (-0.31%)

GLD

SPDR Gold Shares

$137.61

-1.4 (-1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$234.00

0.56 (0.24%)

, JNJ

Johnson & Johnson

$141.00

1.43 (1.02%)

12:53
12/06/19
12/06
12:53
12/06/19
12:53
Hot Stocks
FDA approves Amgen's Avsola »

The U.S. Food and Drug…

AMGN

Amgen

$234.00

0.56 (0.24%)

JNJ

Johnson & Johnson

$141.00

1.43 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 09

    Dec

  • 21

    Jan

SYPR

Sypris Solutions

$0.82

(0.00%)

, UTX

United Technologies

$147.18

1.87 (1.29%)

12:52
12/06/19
12/06
12:52
12/06/19
12:52
Hot Stocks
Sypris subsidiary wins contracts with United Technologies' Collins Aerospace »

Sypris Electronics, a…

SYPR

Sypris Solutions

$0.82

(0.00%)

UTX

United Technologies

$147.18

1.87 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

LDOS

Leidos

$89.47

-0.44 (-0.49%)

12:49
12/06/19
12/06
12:49
12/06/19
12:49
Hot Stocks
Leidos among team awarded DOE contract for Hanford site services »

The U.S. Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMMU

Immunomedics

$20.38

1.86 (10.04%)

12:45
12/06/19
12/06
12:45
12/06/19
12:45
Options
Immunomedics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

12:45
12/06/19
12/06
12:45
12/06/19
12:45
General news
Breaking General news story  »

Week of 12/6 Baker-Hughes…

12:45
12/06/19
12/06
12:45
12/06/19
12:45
General news
Breaking General news story  »

Week of 12/6 Baker-Hughes…

12:40
12/06/19
12/06
12:40
12/06/19
12:40
General news
Treasury's $25 B 2-year FRN reopening stopped at 0.245% »

Treasury's $25 B…

12:40
12/06/19
12/06
12:40
12/06/19
12:40
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

12:30
12/06/19
12/06
12:30
12/06/19
12:30
General news
Treasury's $25 B 2-year FRN reopening stopped at 0.245% »

Treasury's $25 B…

PIR

Pier 1 Imports

$7.70

-0.27 (-3.39%)

12:22
12/06/19
12/06
12:22
12/06/19
12:22
Periodicals
Pier 1 hired Guggenheim amid concerns over debt, Debtwire reports »

Pier 1 Imports has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLA

Medallia

$29.11

-0.68 (-2.28%)

12:19
12/06/19
12/06
12:19
12/06/19
12:19
Recommendations
Medallia analyst commentary  »

Oppenheimer says would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

PIR

Pier 1 Imports

$7.92

-0.05 (-0.63%)

12:19
12/06/19
12/06
12:19
12/06/19
12:19
Periodicals
Breaking Periodicals news story on Pier 1 Imports »

Pier 1 hired financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
12/06/19
12/06
12:17
12/06/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
12/06/19
12/06
12:16
12/06/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$60.70

1.195 (2.01%)

, XLRN

Acceleron

$48.58

-0.08 (-0.16%)

12:08
12/06/19
12/06
12:08
12/06/19
12:08
Hot Stocks
Bristol-Myers, Acceleron: FDA says Reblozyl will not be reviewed at ODAC meeting »

Bristol-Myers Squibb…

BMY

Bristol-Myers

$60.70

1.195 (2.01%)

XLRN

Acceleron

$48.58

-0.08 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

  • 09

    Dec

  • 11

    Dec

  • 04

    Apr

MNTA

Momenta

$17.53

0.68 (4.04%)

12:04
12/06/19
12/06
12:04
12/06/19
12:04
Hot Stocks
Momenta granted orphan status for hemolytic anemia treatment »

The FDA granted Momenta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 16

    Dec

EA

Electronic Arts

$102.74

0.66 (0.65%)

, ATVI

Activision Blizzard

$55.08

0.09 (0.16%)

12:03
12/06/19
12/06
12:03
12/06/19
12:03
Conference/Events
Wedbush digital media analyst to hold an analyst/industry conference call »

Digital Media Analyst…

EA

Electronic Arts

$102.74

0.66 (0.65%)

ATVI

Activision Blizzard

$55.08

0.09 (0.16%)

GME

GameStop

$6.46

0.1 (1.57%)

NTDOY

Nintendo

$0.00

(0.00%)

TTWO

Take-Two

$123.21

-0.69 (-0.56%)

UBSFY

Ubisoft

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 13

    Dec

PRVL

Prevail Therapeutics

$14.02

-0.03 (-0.21%)

12:02
12/06/19
12/06
12:02
12/06/19
12:02
Hot Stocks
Prevail Therapeutics granted orphan status for dementia treatment »

The FDA granted Prevail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEI

Weidai

$4.10

-0.35 (-7.87%)

12:00
12/06/19
12/06
12:00
12/06/19
12:00
Hot Stocks
Weidai falls -8.3% »

Weidai is down -8.3%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.